Oncology Institute, Inc. (TOI) Income from Continuing Operations (2020 - 2026)

Oncology Institute (TOI) has 7 years of Income from Continuing Operations data on file, last reported at 2492000.0 in Q1 2026.

• Quarterly Income from Continuing Operations rose 87.28% year-over-year to 2492000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 43513000.0 (up 32.39% YoY) and the FY2025 annual result came in at 60606000.0, up 6.27% from the prior year.
• Income from Continuing Operations improved to 2492000.0 in Q1 2026, from 7508000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 19286000.0 in Q1 2022 to a low of 29998000.0 in Q1 2023.
• A 5-year average of 12392764.71 and a median of 16113000.0 in 2024 frame the typical range for Income from Continuing Operations.
• Annual changes were most pronounced in 2022 — Income from Continuing Operations soared 2036.35% — and 2023, when it slumped 551.42%.
• Tracing TOI's Income from Continuing Operations over 5 years: stood at 11007000.0 in 2022, then plunged by 70.38% to 18754000.0 in 2023, then increased by 29.71% to 13182000.0 in 2024, then jumped by 43.04% to 7508000.0 in 2025, then soared by 66.81% to 2492000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 2492000.0 (Q1 2026), 7508000.0 (Q4 2025), and 16504000.0 (Q3 2025), per Business Quant data.